首页> 美国卫生研究院文献>Journal of Clinical Research in Pediatric Endocrinology >Impact of Insulin Resistance on Insulin-Like Growth Factor-1/Insulin Like Growth Factor-Binding Protein-3 Axis and on Early Weight Gain in Small for Gestational Age Infants
【2h】

Impact of Insulin Resistance on Insulin-Like Growth Factor-1/Insulin Like Growth Factor-Binding Protein-3 Axis and on Early Weight Gain in Small for Gestational Age Infants

机译:胰岛素抵抗对妊娠期婴儿胰岛素样生长因子-1 /胰岛素样生长因子结合蛋白3轴的影响以及对早期体重的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Objective: To assess insulin-like growth factor-1 (IGF-1)/IGF-binding protein-3 (IGFBP-3) axis and insulin resistance (IR) and the relationship of these parameters with growth in appropriate for gestational age (AGA) and small for gestational age (SGA) infants at birth and in early infancy.M>ethods: Postnatal blood samples for measurement of glucose, insulin, IGF-1, and IGFBP-3 were taken from 60 infants (30 AGA and 30 SGA) at birth and at one, three, and six months of age. Both SGA and AGA infants were divided into two groups: growing well and not growing well. Blood glucose, insulin, IGF-1, and IGFBP-3 values were assessed in all infants.>Results: Homeostasis model assessment-IR (HOMA-IR) values in well-growing SGA infants in the third and sixth months were found to be higher than in not well-growing SGA infants (3.9±0.8 vs. 1.0±0.3 at 3 months and 3.3±0.9 vs. 2.4±0.9 at 6 months, p<0.05). IGF-1 levels in well-growing SGA infants at 3 and 6 months were found to be higher than those in not well-growing SGA infants (83.80±44.50 vs. 73.50±17.60 ng/mL at 3 months and 95.12±50.74 vs. 87.67±22.91 ng/mL at 6 months, p<0.05). The IGF-1 values were significantly lower in well-growing SGA infants than in well-growing AGA infants (83.80±44.50 vs. 103.31±30.81 ng/mL at 3 months and 95.12±50.74 vs. 110.87±26.44 ng/mL at 6 months, p<0.05).>Conclusions: This study demonstrates the effects of accelerated early infant growth on IGF-1/IGFBP-3 axis in SGA-born infants.>Conflict of interest:None declared.
机译:>目的:评估胰岛素样生长因子1(IGF-1)/ IGF结合蛋白3(IGFBP-3)轴和胰岛素抵抗(IR)以及这些参数与生长的关系M > ethods :产后血样,用于测量葡萄糖,胰岛素,IGF-1和IGFBP,适合于胎龄(AGA)和小胎龄(SGA)婴儿。从出生时以及一岁,三岁和六个月的60名婴儿(30 AGA和30 SGA)中抽取-3。 SGA和AGA婴儿均分为两组:生长良好和生长不良。在所有婴儿中评估了血糖,胰岛素,IGF-1和IGFBP-3的值。>结果:在第三和第三代发育良好的SGA婴儿中,稳态模型评估IR(HOMA-IR)值第六个月的婴儿被发现比未发育良好的SGA婴儿高(3个月时为3.9±0.8 vs. 1.0±0.3,6个月时为3.3±0.9 vs. 2.4±0.9,p <0.05)。发现生长良好的SGA婴儿在3个月和6个月时的IGF-1水平高于生长不良的SGA婴儿(3个月时为83.80±44.50 VS. 73.50±17.60 ng / mL,95.12±50.74 VS. 6个月时为87.67±22.91 ng / mL,p <0.05)。生长良好的SGA婴儿的IGF-1值显着低于生长良好的AGA婴儿(3个月时为83.80±44.50 vs.103.31±30.81 ng / mL,6个月时为95.12±50.74 vs.110.87±26.44 ng / mL个月,p <0.05)。>结论::这项研究证明了SGA出生婴儿的早期婴儿生长加速对IGF-1 / IGFBP-3轴的影响。>利益冲突:未声明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号